Get started
Author

Rosa L. Vincent

Observed names: Rosa Vincent, Vincent, Rosa Louise
ORCID: 0000-0003-0742-8977
Observed ORCID: 0000-0003-0742-8977
OpenAlex ID: A5007694810
Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
2020 · Candice R. Gurbatri, Ioana Lia, et al. · Science Translational Medicine · 665
PDF
Probiotic-guided CAR-T cells for solid tumor targeting
2023 · Rosa L. Vincent, Candice R. Gurbatri, et al. · Science · 288
PDF
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 · Andrew Redenti, Jongwon Im, et al. · Nature · 231
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunity
2023 · Thomas M. Savage, Rosa L. Vincent, et al. · Science Advances · 176
Programmable bacteria synergize with PD-1 blockade to overcome cancer cell–intrinsic immune resistance mechanisms
2024 · Fangda Li, Zaofeng Yang, et al. · Science Immunology · 64
PDF
The emerging landscape of engineered bacteria cancer therapies
2025 · Edward R. Ballister, Alexander Michels, et al. · Nature Biotechnology · 35
CAR-T cells SEAK help from enzymes
2021 · Rosa Vincent, Tal Danino · Nature Chemical Biology · 4
Abstract 6248: Engineered probiotics for local delivery of checkpoint blockade nanobodies
2020 · Candice Gurbatri, Ioana Lia, et al. · Cancer Research · 4
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models
2026 · Mathieu Rouanne, Noah Chen, et al. · Science Translational Medicine · 3
PDF
Abstract 5237: Engineered probiotics direct the antigen specificity of CAR-T cells in situ
2024 · Rosa L. Vincent, Fangda Li, et al. · Cancer Research · 2
Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells
2024 · Rosa L. Vincent, Fangda Li, et al. · Journal of Visualized Experiments · 1
NanoPro – a Framework for Probiotically-Guided Nanovector Therapy
2026 · Alexander Michels, Azra Haseki, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 1348: Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy.
2026 · Mathieu Rouanne, Noah Chen, et al. · Cancer Research
936 Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy
2025 · Mathieu Rouanne, Noah Chen, et al. · Journal for ImmunoTherapy of Cancer
PDF
Abstract B015: Toxin-producing bacterial therapy limits tumor growth in autochthonous mouse models of pancreatic ductal adenocarcinoma
2024 · Amanda R. Decker-Farrell, Stephen A. Sastra, et al. · Cancer Research
Works count: 16
Citation count: 1,473
H-index: 6
I10-index: 6
Year
Topic
Type